Reports
Reports
Sale
The global normal saline for parenteral use market was valued at USD 3.38 billion in 2023, due to rising incidence of chronic diseases that often involve the use of intravenous fluids like normal saline across the globe. The market is expected to grow at a CAGR of 5.50% during the forecast period of 2024-2032 with the values likely to reach USD 5.48 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Normal saline for parenteral use, also known as 0.9% sodium chloride solution, is a sterile solution of sodium chloride (NaCl) in water. It is isotonic to human blood and tissues, meaning its concentration of salt matches that of the body's fluids. This makes it suitable for various medical applications. The medical uses include fluid replacement, which is used to restore fluid balance in patients who are dehydrated or experiencing fluid loss due to illness, surgery, or trauma. The solution helps maintain electrolyte levels, particularly sodium and chloride ions, essential for nerve function, muscle contraction, and cellular homeostasis. Other application includes wound care used to irrigate to cleanse and maintain moisture balance in wounds.
Increasing Surgical Volumes
The growth in surgical interventions worldwide is a significant driver for the market. Surgical procedures, both elective and emergency, often require intravenous fluids for hydration, electrolyte balance, and medication administration, thereby, boosting the demand for normal saline solutions. According to an article published by The Lancet, approximately 313 million surgical procedures undertaken worldwide each year.
Hence, the rise in surgical volumes leads to growth in the global normal saline market for parenteral use by increasing the demand for intravenous fluids during surgeries, supporting fluid management and electrolyte balance, facilitating surgical procedures, and aiding in postoperative recovery and thus driving the market growth.
Increasing Cases of Chronic Diseases is Expected to Propel Normal Saline for Parenteral Use Market Demand
The chronic diseases such as cardiovascular diseases, diabetes, kidney disorders, and respiratory conditions require ongoing medical management. Many patients with chronic illnesses require regular hospital visits, treatments, and sometimes surgeries. Normal saline is commonly used in these settings to maintain hydration, electrolyte balance, and facilitate medication administration.
Patients with chronic diseases often require intravenous therapies as part of their treatment regimen. Normal saline serves as a foundational fluid for these therapies, ensuring patients receive essential fluids and electrolytes to manage their conditions effectively, and thus driving the market demand.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Key Trends | Impact |
Shift towards Home Healthcare | There is a growing preference for home-based medical care and outpatient treatments, driven by cost-effectiveness, patient convenience, and advancements in medical technology. Normal saline, along with other intravenous fluids, is increasingly used in home healthcare settings, supported by advancements in portable infusion pumps and caregiver training and is expected to drive the market growth. |
Collaborative Initiatives and Partnerships | The strategic collaborations between healthcare providers, pharmaceutical companies, and medical device manufacturers aim to enhance product innovation, market penetration, and patient care outcomes. These partnerships facilitate joint research, development of advanced technologies, and geographical expansion into new markets and is acting as opportunity for the market growth. |
Technological Advancements | The continuous innovations in intravenous therapy devices and formulations improve the safety, efficacy, and administration of normal saline. Advanced packaging solutions, improved sterility assurance, and compatibility with medications enhance patient care and operational efficiency in healthcare settings, augmenting the market growth. |
Market Breakup by Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Type is Anticipated to Witness Substantial Growth
By type, the market is segmented into plastic bottles and glass bottles. The plastic bottles segment is expected to hold a major share as plastic bottles are they are more compatible with modern healthcare practices such as automated filling lines and logistics systems. They can be manufactured in a way that ensures sterility and prevents leaching of harmful substances into the saline solution.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the region, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is dominating the market share as the aging population in North America, coupled with increasing chronic diseases and surgical procedures, has led to a higher demand for medical supplies, including normal saline. This demographic trend drives market regional growth as healthcare facilities stock up on essential supplies.
Europe also holds a high normal saline for parenteral use market value as advances in medical technology and manufacturing processes contribute to the growth of the normal saline market in Europe. Innovations in packaging, formulation, and delivery systems enhance the usability, efficiency, and safety of parenteral solutions, meeting the evolving needs of healthcare providers and thus driving the market’s growth.
Additionally, Asia Pacific is expected to witness substantial market growth as APAC countries are witnessing a significant increase in surgical volumes due to population growth, aging demographics, and the epidemiological transition towards non-communicable diseases which requires high demand for normal saline for parenteral use and driving the market growth.
The key features of the market report include strategic initiatives such as recent partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Baxter International, Inc.
Baxter International is one of the leading manufacturers and suppliers of normal saline solutions globally. The company's extensive portfolio includes a range of intravenous solutions, including 0.9% Sodium Chloride (normal saline), which is widely used in healthcare settings for hydration, medication administration, and various medical procedures.
Pfizer, Inc.
Pfizer, Inc. a leading provider of injectable drugs and infusion technologies and well-known for its portfolio of intravenous solutions, including normal saline (0.9% Sodium Chloride).
Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Factory, Inc. manufactures and supplies a range of intravenous solutions, including normal saline (0.9% Sodium Chloride). These products are critical in healthcare settings for fluid and electrolyte replenishment, medication administration, and other medical procedures.
Other key players in the market include ICU Medical, Inc., Sichuan Kelun Pharmaceutical Co., Ltd., B. Braun Melsungen AG, Alcare pharmaceuticals pte Ltd, SOXA FORMULATIONS & RESEARCH PVT. LTD., NIRMA LIMITED, and Advacare Pharma USA, LLC. among others.
Kindly note that this only represents a partial list of companies and the complete list has been in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Normal Saline for Parenteral Use Market Overview
3.1 Global Normal Saline for Parenteral Use Market Historical Value (2017-2023)
3.2 Global Normal Saline for Parenteral Use Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Normal Saline for Parenteral Use Market Landscape*
5.1 Global Normal Saline for Parenteral Use: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Normal Saline for Parenteral Use: Product Landscape
5.2.1 Analysis by Type
5.2.2 Analysis by Volume/size
6 Global Normal Saline for Parenteral Use Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Normal Saline for Parenteral Use Market Segmentation (2017-2032)
7.1 Global Normal Saline for Parenteral Use Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Plastic Bottles
7.1.3 Glass Bottles
7.2 Global Normal Saline for Parenteral Use Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Intramuscular Injection
7.2.3 Intravenous Injection
7.3 Global Normal Saline for Parenteral Use Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Specialty Clinics
7.3.4 Ambulatory Surgical Centers
7.3.5 Others
7.4 Global Normal Saline for Parenteral Use Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Normal Saline for Parenteral Use Market (2017-2032)
8.1 North America Normal Saline for Parenteral Use Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Plastic Bottles
8.1.3 Glass Bottles
8.2 North America Normal Saline for Parenteral Use Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Intramuscular Injection
8.2.3 Intravenous Injection
8.3 North America Normal Saline for Parenteral Use Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Specialty Clinics
8.3.4 Ambulatory Surgical Centers
8.3.5 Others
8.4 North America Normal Saline for Parenteral Use Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Normal Saline for Parenteral Use Market (2017-2032)
9.1 Europe Normal Saline for Parenteral Use Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Plastic Bottles
9.1.3 Glass Bottles
9.2 Europe Normal Saline for Parenteral Use Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Intramuscular Injection
9.2.3 Intravenous Injection
9.3 Europe Normal Saline for Parenteral Use Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Specialty Clinics
9.3.4 Ambulatory Surgical Centers
9.3.5 Others
9.4 Europe Normal Saline for Parenteral Use Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Normal Saline for Parenteral Use Market (2017-2032)
10.1 Asia Pacific Normal Saline for Parenteral Use Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Plastic Bottles
10.1.3 Glass Bottles
10.2 Asia Pacific Normal Saline for Parenteral Use Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Intramuscular Injection
10.2.3 Intravenous Injection
10.3 Asia Pacific Normal Saline for Parenteral Use Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Specialty Clinics
10.3.4 Ambulatory Surgical Centers
10.3.5 Others
10.4 Asia Pacific Normal Saline for Parenteral Use Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Normal Saline for Parenteral Use Market (2017-2032)
11.1 Latin America Normal Saline for Parenteral Use Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Plastic Bottles
11.1.3 Glass Bottles
11.2 Latin America Normal Saline for Parenteral Use Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Intramuscular Injection
11.2.3 Intravenous Injection
11.3 Latin America Normal Saline for Parenteral Use Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Specialty Clinics
11.3.4 Ambulatory Surgical Centers
11.3.5 Others
11.4 Latin America Normal Saline for Parenteral Use Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032)
12.1 Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032) by Sensor Type
12.1.1 Market Overview
12.1.2 Plastic Bottles
12.1.3 Glass Bottles
12.2 Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Intramuscular Injection
12.2.3 Intravenous Injection
12.3 Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Specialty Clinics
12.3.4 Ambulatory Surgical Centers
12.3.5 Others
12.4 Middle East and Africa Normal Saline for Parenteral Use Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Supplier Landscape
14.1 Market Share Analysis, By Region (Top 5 Companies)
14.1.1 Market Share Analysis: Global
14.1.2 Market Share Analysis: North America
14.1.3 Market Share Analysis: Europe
14.1.4 Market Share Analysis: Asia-Pacific
14.1.5 Market Share Analysis: Others
14.2 Baxter International, Inc.
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 Pfizer Inc.
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Otsuka Pharmaceutical Co.
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 ICU Medical, Inc.
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 Sichuan Kelun Pharmaceutical Co., Ltd.
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 B. Braun Melsungen AG
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Alcare pharmaceuticals pte ltd
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 SOXA FORMULATIONS & RESEARCH PVT. LTD.
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 NIRMA LIMITED
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic Reach and Achievements
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Advacare Pharma USA, LLC.
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 Global Normal Saline for Parenteral Use Market – Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive, moreover we can provide analysis of companies as per custom request.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.